Amendment to Regulation (EU) 2024/795
This procedure aims to ensure that essential medicines are available and secure in the EU. It addresses potential shortages and aims to make important medicines more accessible to all citizens, strengthening public health resilience.
The proposal affects patients, healthcare providers, and the pharmaceutical industry. It seeks to amend existing regulations to better manage the supply chain and availability of medicines crucial for public health.
Documents
Amendment to Regulation (EU) 2024/795
report · EN · 2026-05-02
Amendment to Regulation (EU) 2024/795
proposal · EN · 2026-05-02
Amendment to Regulation (EU) 2024/795
report · EN · 2026-05-02
Amendment to Regulation (EU) 2024/795
report · EN · 2026-05-02
Amendment to Regulation (EU) 2024/795
report · EN · 2026-05-02
Amendment to Regulation (EU) 2024/795
report · EN · 2026-05-02
Amendment to Regulation (EU) 2024/795
position · EN · 2026-05-02